贝伐单抗用于非小细胞肺癌。 - Suppr | 超能文献

Bevacizumab for non-small-cell lung cancer.

作者信息

Sculier Jean-Paul, Meert Anne-Pascale, Paesmans Marianne

出版信息

N Engl J Med. 2007 Mar 29;356(13):1373-4; author reply 1374-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌。

N Engl J Med. 2007 Mar 29;356(13):1373-4; author reply 1374-5.

2

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌。

N Engl J Med. 2007 Mar 29;356(13):1373; author reply 1374-5. doi: 10.1056/NEJMc070042.

3

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌。

N Engl J Med. 2007 Mar 29;356(13):1374; author reply 1374-5.

4

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌

N Engl J Med. 2007 Mar 29;356(13):1373; author reply 1374-5.

5

Improved survival with addition of bevacizumab to paclitaxel and carboplatin in elderly patients with non-small-cell lung cancer.在老年非小细胞肺癌患者中，在紫杉醇和卡铂基础上加用贝伐单抗可提高生存率。

J Clin Oncol. 2008 Apr 20;26(12):2063-4; author reply 2064-5. doi: 10.1200/JCO.2008.16.3337.

6

In focus: non-small cell lung cancer: E1505.聚焦：非小细胞肺癌：E1505。

Clin Adv Hematol Oncol. 2007 Mar;5(3):206-8.

7

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.单独使用紫杉醇-卡铂或联合贝伐单抗治疗非小细胞肺癌。

N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884.

8

Reporting of subset analysis: where do we draw the line?亚组分析的报告：我们该如何界定？

J Clin Oncol. 2008 Apr 20;26(12):2062-3; author reply 2064-5. doi: 10.1200/JCO.2008.16.2354.

9

Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.点破研究的治疗原理和研究设计：培美曲塞/卡铂/贝伐珠单抗联合治疗继以培美曲塞/贝伐珠单抗维持治疗与紫杉醇/卡铂/贝伐珠单抗联合治疗继以贝伐珠单抗维持治疗用于 IIIB 或 IV 期非鳞状非小细胞肺癌患者的随机、开放标签 III 期研究。

Clin Lung Cancer. 2009 Jul;10(4):252-6. doi: 10.3816/CLC.2009.n.035.

10

Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men?贝伐单抗联合化疗用于非小细胞肺癌：在寻找几个合适的人？

Clin Lung Cancer. 2008 Mar;9(2):75-6. doi: 10.3816/CLC.2008.n.011.

引用本文的文献

1

Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.抗血管内皮生长因子（VEGF）和抗 VEGF 受体在小鼠健康组织中引起的血管改变。

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12018-23. doi: 10.1073/pnas.1301331110. Epub 2013 Jul 1.

2

Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.在斑马鱼肿瘤模型中，缺氧诱导的病理性血管生成介导肿瘤细胞的播散、侵袭和转移。

Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19485-90. doi: 10.1073/pnas.0909228106. Epub 2009 Nov 3.